Clinical targets of A2B adenosine receptor antagonists

被引：0
|
作者：
Linden, J
Figler, RA
Jacobson, KA
Wang, GQ
LaNoue, KF
机构：
[1] Univ Virginia, Sch Med, Dept Mol Physiol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Dept Biol Phys, Charlottesville, VA 22908 USA
[3] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA
[4] Adenosine Therapeut LLC, Charlottesville, VA USA
[5] NIH, Bethesda, MD 20892 USA
[6] Penn State Univ, Hershey, PA USA
来源：
DRUG DEVELOPMENT RESEARCH | 2002年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
51
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [41] Allosteric modulators of human A2B adenosine receptor
    Trincavelli, Maria Letizia
    Giacomelli, Chiara
    Daniele, Simona
    Taliani, Sabrina
    Cosimelli, Barbara
    Laneri, Sonia
    Severi, Elda
    Barresi, Elisabetta
    Pugliesi, Isabella
    Greco, Giovanni
    Novellino, Ettore
    Da Settimo, Federico
    Martini, Claudia
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2014, 1840 (03): : 1194 - 1203
  • [42] Effects of adenosine A2B receptor blockade on atherosclerosis
    Linden, Joel
    Harmon, R. Chris
    Figler, Robert A.
    Herenbrink, Carmen Klein
    Pei, Hong
    Wu, Runpei
    IJzerman, Ad
    Hedrick, Catherine C.
    PURINERGIC SIGNALLING, 2014, 10 (04) : 678 - 678
  • [43] QSAR and docking analysis of A2B adenosine receptor antagonists based on non-xanthine scaffold
    Mahboubeh Mansourian
    Afshin Fassihi
    Lotfollah Saghaie
    Armin Madadkar-Sobhani
    Karim Mahnam
    Maryam Abbasi
    Medicinal Chemistry Research, 2015, 24 : 394 - 407
  • [44] Exploring the structural determinants of novel xanthine derivatives as A2B adenosine receptor antagonists: a computational study
    Yang, Yinfeng
    Li, Yan
    Zhou, Weiwei
    Chen, Yaorong
    Wu, Qian
    Pan, Yanqiu
    Zhang, Shuwei
    Yang, Ling
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (13): : 3467 - 3481
  • [45] Novel dual A2A A2B adenosine receptor antagonists for cancer immunotherapy: in vitro and in vivo characterization
    Galezowski, Michal
    Wegrzyn, Paulina
    Bobowska, Aneta
    Dziedzic, Katarzyna
    Szeremeta-Spisak, Joanna
    Nowogrodzki, Marcin
    Satala, Grzegorz
    Obara, Alicja
    Lozinska-Raj, Iwona
    Dudek, Marcelina
    Janiga, Anita
    Reus, Jacek
    Wronowski, Marek
    Zastawna, Magdalena
    Statkiewicz, Grzegorz
    Rogacki, Maciej
    Ziembik, Magdalena
    Grycuk, Karolina
    Soukou, Foteini
    Michalik, Kinga
    Adamus, Agnieszka
    Wiatrowska, Karolina
    Lewandowska, Natalia
    Golas, Aniela
    Haberkiewicz, Olga
    Porter, Rod
    Brzozka, Krzysztof
    Nowak, Mateusz
    CANCER RESEARCH, 2019, 79 (13)
  • [46] QSAR and docking analysis of A2B adenosine receptor antagonists based on non-xanthine scaffold
    Mansourian, Mahboubeh
    Fassihi, Afshin
    Saghaie, Lotfollah
    Madadkar-Sobhani, Armin
    Mahnam, Karim
    Abbasi, Maryam
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (01) : 394 - 407
  • [47] Discovery of potent and selective bicyclic A2B adenosine receptor antagonists via bioisosteric amide replacement
    Eastwood, Paul
    Gonzalez, Jacob
    Paredes, Sergio
    Fonquerna, Silvia
    Cardus, Arantxa
    Antonio Alonso, Juan
    Nueda, Arsenio
    Domenech, Teresa
    Reinoso, Raquel F.
    Vidal, Bernat
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1634 - 1637
  • [48] Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists
    El-Tayeb, Ali
    Michael, Sebastian
    Abdelrahman, Aliaa
    Behrenswerth, Andrea
    Gollos, Sabrina
    Nieber, Karen
    Mueller, Christa E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (12): : 890 - 895
  • [49] Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives
    Deb, Pran Kishore
    Chandrasekaran, Balakumar
    Mailavaram, Raghuprasad
    Tekade, Rakesh Kumar
    Jaber, Abdul Muttaleb Yousef
    DRUG DISCOVERY TODAY, 2019, 24 (09) : 1854 - 1864
  • [50] Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists
    Vlachodimou, Anna
    de Vries, Henk
    Pasoli, Milena
    Goudswaard, Miranda
    Kim, Soon-Ai
    Kim, Yong-Chul
    Scortichini, Mirko
    Marshall, Melissa
    Linden, Joel
    Heitman, Laura H.
    Jacobson, Kenneth A.
    IJzerman, Adriaan P.
    BIOCHEMICAL PHARMACOLOGY, 2022, 200
12345